Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Antonin Levy MD

Antonin Levy MD

Associate Professor, Department of Radiation Oncology, Gustave Roussy Cancer Centre, Villejuif, Université Paris-Saclay, France.

Antonin Levy, MD, PhD, is an associate professor in the Department of Radiation Oncology at Gustave Roussy Cancer Centre, Villejuif, Université Paris-Saclay, France.

Dr. Levy has authored or co-authored over 160 articles with a special focus on thoracic malignancies and drug-radiation therapy association. His work in immunotherapy of thoracic malignancies includes participation in multiple clinical trials and he is the principal investigator of a randomized phase III trial evaluating multisite irradiation in advanced NSCLC receiving PD-(L)1 checkpoint inhibitors.


Dr. Levy reports the following disclosures; 

Academic grants for research: Amgen, Astra-Zeneca and Roche.